Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Page 1
Deep Learning-Based Diagnostic Model for Ocular Surface Neoplastic Diseases.
Sakata R, Shijo T, Ueno Y, Oda M, Kitaguchi Y, Taki Y, Maehara H, Nejima R, Miyata K, Inomata T, Fukuoka H, Miyazaki D, Noma H, Mori K, Yamaguchi T. Sakata R, et al. Am J Ophthalmol. 2026 Jun;286:184-195. doi: 10.1016/j.ajo.2026.02.033. Epub 2026 Feb 24. Am J Ophthalmol. 2026. PMID: 41748055
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.
Pakvisal N, Wongkongkathep P, Bunrasmee W, Sodsai P, Siriluksana J, Boonnak N, Sangcharoen T, Trakarnsanga B, Sukprakun S, Wantanasiri P, Chotirosniramit K, Phanichkrivalkosil M, Nanthawong S, Chanchaem P, Mankhong S, Kumpunya S, Supabphol S, Sirijun N, Kongtragulsub K, Pearngam P, Somparn P, Payne DM, Zhao B, Praphanphoj V, Pornputtapong N, Sriswasdi S, Wichadakul D, Uttamapinan S, Angspatt P, Wongchanapat P, Teeyapun N, Luangdilok S, Sitthideatphaiboon P, Susiriwatananont T, Zungsontiporn N, Parinyanitikul N, Tanasanvimon S, Vinayanuwattikun C, Salazar A, Hirankarn N, Sriuranpong V, Pisitkun T. Pakvisal N, et al. Clin Cancer Res. 2026 May 7. doi: 10.1158/1078-0432.CCR-25-4271. Online ahead of print. Clin Cancer Res. 2026. PMID: 42095629
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.
Vieito M, Fontana E, Han CH, Castanon E, Pinato DJ, Bechter O, Eefsen RL, Moreno I, Prenen H, Dummer R, Plummer R, Schnetzler G, Kornacker M, Pettazzoni P, Renner F, About M, Serrano-Serrano ML, Godfried Sie C, Keelara A, Roller A, Dejardin D, Cinato E, Fakolade T, Guarin E, Flinn N, Kratochwil NA, Keshelava N. Vieito M, et al. J Clin Oncol. 2026 May 10;44(14):1337-1348. doi: 10.1200/JCO-25-02444. Epub 2026 Mar 27. J Clin Oncol. 2026. PMID: 41894647 Clinical Trial.